Mitchell Jenkins

Assistant Professor

Last publication 2022 Last refreshed 2026-05-16

faculty

Internal Med, College of Medicine

4 pubs

Biography and Research Information

OverviewAI-generated summary

Mitchell Jenkins' research focuses on improving patient outcomes through evidence-based medical practices and stewardship. His work has investigated the impact of vancomycin use in academic medical centers, exploring strategies to optimize its application and reduce its utilization while maintaining patient safety. Jenkins has also examined the clinical outcomes of patients with multiple myeloma, specifically looking at the effects of viral infections like influenza and human rhinovirus on morbidity and mortality. His research in this area includes comparing outcomes between vaccinated and unvaccinated patient cohorts. Jenkins collaborates with researchers at the University of Arkansas for Medical Sciences on these studies.

Metrics

  • Publications: 4

Selected Publications

  • 1791. Leveraging EMR Alerts for Vancomycin Time Outs (2022)
  • 1790. Dethroning Vancomycin: A Multifaceted Stewardship Approach to Reduce Vancomycin in an Academic Medical Center (2022)
  • 17. A Retrospective Cohort Study of Influenza Infected Multiple Myeloma Patients Comparing Clinical Outcomes Between Vaccinated and Unvaccinated (2021)
  • 1327. Human Rhinovirus Infection in Multiple Myeloma Patients: Effect on Morbidity and Mortality (2021)

View all publications on OpenAlex →

Collaboration Network

10 Collaborators 3 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics